Monte Rosa Therapeutics, Inc.

GLUE chart

Monte Rosa Therapeutics, Inc. news

• Could You Have Seen The Run In Kymera Stock Coming?

  trefis.com · Oct 26, 5:34 PM EDT

• Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 24, 3:42 PM EDT

• Monte Rosa Therapeutics, Inc. (GLUE) stock price, news, quote and history

  Yahoo Finance UK · Oct 23, 7:59 PM EDT

• Monte Rosa Therapeutics, Inc. Estimates – NASDAQ:GLUE

  TradingView · Oct 23, 12:56 PM EDT

• Are Options Traders Betting on a Big Move in Monte Rosa Therapeutics Stock?

  Yahoo Finance · Oct 23, 6:51 AM EDT

• 189,430 Shares in Monte Rosa Therapeutics, Inc. $GLUE Purchased by Assenagon Asset Management S.A.

  MarketBeat · Oct 22, 3:34 AM EDT

• Monte Rosa's MRT-8102 Shows Biomarker Gains in GFORCE-1 Study

  marketbeat.com · Oct 6, 3:02 AM EDT

• Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Yahoo Finance · Oct 2, 4:01 PM EDT

• Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

  Yahoo Finance · Oct 1, 7:00 AM EDT

• Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk

  Yahoo Finance · Sep 30, 4:01 PM EDT

• Novartis (NVS) Just Handed Monte Rosa (GLUE) A $50M Milestone

  Yahoo Finance · Sep 13, 5:29 AM EDT

• Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon

  Yahoo Finance · Sep 8, 11:45 AM EDT

Monte Rosa Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-01
• 8-K8-K2026-09-08
• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• 8-K8-K2026-06-11
• 10-Q10-Q2026-05-07
• 8-K8-K2026-05-07
• DEF 14ADEF 14A2026-04-29
• 10-K10-K2026-03-17
• 8-K8-K2026-03-17
• 8-K8-K2026-02-10
• 8-K8-K2026-01-09

About Monte Rosa Therapeutics, Inc.

Ticker

GLUE (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Boston, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1826457

Former names

Monte Rosa Therapeutics, Inc.

Frequently asked questions